Tradestie Institutional Equity Comparison Engine
HAO vs CHAD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HAO Overall Edge
HAO Captures Institutional Edge (2โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haoxi Health Technology Limited Class A Ordinary Shares (HAO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, HAO trades at N/M Forward P/E with -14.9% operating margin (+137.3% YoY revenue) versus CHAD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HAO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CHAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
HAO N/M vs CHAD N/M Fwd P/E
Growth & Margin Winner
HAO
Op Margin -14.9% vs N/A ยท YoY +137.3% vs N/A
Momentum & Technical Winner
HAO
1Y +112.5% vs +19.6% ยท 52W Pos 36% vs 100%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HAO
NASDAQ
Haoxi Health Technology Limited Class A Ordinary Shares
Services-Advertising Agencies
$2.00
-4.09% 1D
Market Cap
$1.3M
1M Return
-5.45%
1Y Return
+112.46%
Forward P/E
N/M
Unified AI Score
55.9 / 100
HOLD
Tech 70.0
Fund 45.0
Flow 50.0
Mom 58.9
CHAD
US Equity
CHAD
Institutional Equity
$10.00
+0.21% 1D
Market Cap
N/A
1M Return
+7.07%
1Y Return
+19.62%
Forward P/E
N/M
Unified AI Score
53.8 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HAO +112.46%
CHAD +19.62%
Spread: +61.12 pp (CHAD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HAO TTM Op. Margin: -14.9%
CHAD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAO vs CHAD. Trailing 12-month operating profitability (HAO -14.9% vs CHAD N/A) and valuation multiples (HAO N/M vs CHAD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HAO | CHAD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3M | N/A | Larger Scale | HAO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +137.3% | N/A | Higher Growth | HAO |
| Operating Margin (TTM) Profitability | -14.9% | N/A | Higher Margin | HAO |
| Net Profit Margin Profitability | -17.4% | N/A | Higher Margin | HAO |
| Return on Equity (ROE) Capital Efficiency | -54.1% | N/A | Higher ROE | HAO |
| 52-Week Range Position Momentum | 36% ($0โ$5) | 100% ($7โ$10) | Stronger Trend | CHAD |
| Beta / 30D Volatility Risk Regime | 7.50ฮฒ ยท 151% Vol | 0.71ฮฒ ยท 11% Vol | Lower Realized Risk | CHAD |
| Unified Institutional Score Composite Signal | 55.9 / 100 (HOLD) | 53.8 / 100 (HOLD) | Higher Composite | HAO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HAO vs CHAD Buy Guide
HAO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CHAD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HAO nor CHAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.